FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor (Q57239064)

From Wikidata
Jump to navigation Jump to search
article by Nai-Kong V. Cheung et al published 20 June 2006 in Journal of Clinical Oncology
edit
Language Label Description Also known as
English
FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor
article by Nai-Kong V. Cheung et al published 20 June 2006 in Journal of Clinical Oncology

    Statements

    FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor (English)
    0 references
    0 references
    0 references
    Nai-Kong V. Cheung
    0 references
    Rebecca Sowers
    0 references
    Irene Y. Cheung
    0 references
    Brian H. Kushner
    0 references
    20 June 2006
    0 references
    24
    0 references
    18
    0 references
    2885-2890
    0 references

    Identifiers

    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit